Menu
Menu
Shaanxi Baisfu Bioengineering Co., Ltd. Launches Innovative Product Megastinmatrienone
Recently, Shaanxi Baisfu Bioengineering Co., Ltd. announced the successful launch of an innovative product, Megastinmatrienone. The introduction of this product marks a significant breakthrough for the company in the field of fragrance and flavor R&D.
Megastinmatrienone is a compound with unique aroma and properties. Its complex molecular structure endows it with excellent performance in a variety of application scenarios. After years of dedicated research, the R&D team of Shaanxi Baisfu Bioengineering Co., Ltd. has successfully achieved large-scale production of Megastinmatrienone through in-depth exploration of natural products and the application of advanced synthesis technologies.
A relevant person in charge of the company stated, “The R&D of Megastinmatrienone is the result of the long-term efforts of our team. We are committed to providing customers with higher-quality and more innovative fragrance and flavor products. This product not only has a unique aroma profile but also excels in stability and durability, meeting the diverse needs of multiple industries such as food and beverage, daily chemicals, tobacco, and pharmaceuticals.”
Since its establishment in 2019, Shaanxi Baisfu Bioengineering Co., Ltd. has been dedicated to the R&D, production, and sales of fragrances and flavors. The company is located in a prime location, at Building A, Baode Yungu International, No. 52 Jinyi 1st Road, Yanta District, Xi’an City, Shaanxi Province, with convenient transportation. After years of development, the company’s registered capital has reached 3 million yuan, and it has obtained various certifications, including China GPM, ISO9001, ISO14001, kosher, HALAL, Eurofins Analysis, etc. The strict quality control system ensures the high quality of its products.
Currently, the company’s products are distributed in more than 30 countries and regions around the world, and it has established good cooperative relationships with many renowned international and domestic enterprises. The launch of Megastinmatrienone will further enrich the company’s product portfolio and enhance its competitiveness in the global market. In the future, Shaanxi Baisfu Bioengineering Co., Ltd. will continue to increase R&D investment, constantly explore and innovate, and bring more high-quality products and solutions to the industry.